The tumor with the two POLE mutations, the c.901G>A, p.Asp301Asn, and the c.1376C>T, p.Ser459Phe, did not exhibit any alteration in the five markers, and it was consequently classified as MSS. This evidence concerns the gene POLE and neoplasm.